- Cell Biology
- Product Type
- Research Area
- New Products
- About Tocris
- Contact Us
Lipoxygenases (LOXs) are a family of non-heme iron dioxygenases that are involved in the production and metabolism of fatty acid hydroperoxidases. There are six lipoxygenase isozymes; 5-LOX, 12R-LOX, 12S-LOX, 15-LOX-1, 15-LOX-2 and E-LOX.
|Cat No||Product Name / Activity|
|5- and 12-Lipoxygenase inhibitor|
|Orally active 5-lipoxygenase activating protein (FLAP) inhibitor|
|Inhibitor of 5-lipoxygenase-activating protein (FLAP)|
|Selective 15-lipoxygenase inhibitor|
|Endogenous inhibitor of 5-lipoxygenase|
|5-, 12-, 15-Lipoxygenase inhibitor|
|5-LOX inhibitor; orally bioavailable|
Lipoxygenases (LOXs) are a family of non-heme iron dioxygenases that are involved in the production and metabolism of fatty acid hydroperoxidases. There are six lipoxygenase isozymes; 5-LOX, 12R-LOX, 12S-LOX, 15-LOX-1 and 15-LOX-2, which catalyze the regio-selective addition of oxygen into arachidonic acid, and epidermal LOX (E-LOX) which metabolizes 12R-hydroperoxyeicosatetraenoic acid (12R-HPETE) to a specific epoxyalcohol compound.
Different isozymes have different physiological roles; 5-, 12R-, 12S- and 15-LOX-1 have proliferative, antiapoptotic and angiogenic functions whilst 15-LOX-2 has roles in differentiation, growth arrest and the induction of apoptosis. E-LOX, the most divergent member of this family, is involved in terminal differentiation of keratinocytes and has a major role in skin barrier function. Perturbations in lipoxygenase enzymes have been implicated in various human diseases including bronchial asthma, atherosclerosis, osteoporosis and some cancers.
|Gene||Species||Gene Symbol||Gene Accession No.||Protein Accession No.|